Literature DB >> 19381766

Dopamine agonists and therapy compliance.

Donald Grosset1.   

Abstract

Dopamine replacement therapy in Parkinson's disease improves motor symptoms, however some patients suffer from motor and behavioural disturbances attributable to taking doses of medication well beyond the dose required to treat their motor disabilities. Dopamine dysregulation syndrome (DDS) can be regarded as a pattern of compulsive medication use, leading to disabling motor and behavioural features. DDS, probably attributed to pulsatile overstimulation of the limbic dopaminergic system, is characterised by severe dopamine addiction and behavioural disorders such as pathological gambling (PG), hypersexuality, punding and mood swings. PG is a form of impulse control disorder (ICD), consisting of persistent and maladaptive gambling of various types, which affects personal, family and occupational activity. The treatment of the syndrome is difficult, hence a strict adherence to antiparkinson medication should be encouraged for prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19381766     DOI: 10.1007/s10072-008-1050-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

Review 1.  Clinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson's disease.

Authors:  Lindy D Wood
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 2.  Parkinson's disease: oxidative stress and therapeutic approaches.

Authors:  Sankar Surendran; Srinivasagam Rajasankar
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

Review 3.  Management of motor and non-motor symptoms in Parkinson's disease.

Authors:  Fabienne Sprenger; Werner Poewe
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

4.  Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease.

Authors:  Sanskriti Sasikumar; Roberto Matta; Renato P Munhoz; Mateusz Zurowski; Yu-Yan Poon; Mojgan Hodaie; Suneil K Kalia; Andres M Lozano; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2021-03-11

5.  Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects.

Authors:  Polyvios Demetriades; Hugh Rickards; Andrea Eugenio Cavanna
Journal:  Parkinsons Dis       Date:  2011-02-20

Review 6.  Dopamine Agonists and Impulse Control Disorders: A Complex Association.

Authors:  Marie Grall-Bronnec; Caroline Victorri-Vigneau; Yann Donnio; Juliette Leboucher; Morgane Rousselet; Elsa Thiabaud; Nicolas Zreika; Pascal Derkinderen; Gaëlle Challet-Bouju
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

7.  Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.

Authors:  Anna Sauerbier; Philipp Loehrer; Stefanie T Jost; Shania Heil; Jan N Petry-Schmelzer; Johanna Herberg; Pia Bachon; Salima Aloui; Alexandra Gronostay; Lisa Klingelhoefer; J Carlos Baldermann; Daniel Huys; Christopher Nimsky; Michael T Barbe; Gereon R Fink; Pablo Martinez-Martin; K Ray Chaudhuri; Veerle Visser-Vandewalle; Lars Timmermann; Daniel Weintraub; Haidar S Dafsari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-09-11       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.